Hugenschmidt, Harald http://orcid.org/0000-0002-1114-5366
Labori, Knut Jørgen
Brunborg, Cathrine
Verbeke, Caroline Sophie
Seeberg, Lars Thomas
Bendigtsen Schirmer, Cecilie
Renolen, Anne
Borgen, Elin
Naume, Bjørn
Wiedswang, Gro
Funding for this research was provided by:
Helse Sør-Øst RHF
Article History
Received: 26 November 2019
Accepted: 7 October 2020
First Online: 16 November 2020
Ethics approval and consent to participate
: All patients selected for surgery were offered participation in this prospective, observational study and asked for their written informed consent. Exclusion criteria were a history of other malignancies in the past 10 years, failure to adhere to standard treatment and infrequent cancer types such as neuroendocrine carcinoma. The study protocol was approved by the Regional Ethical Committee (Helse Sør-Øst; Ref. 93-08172d 6.2008.540) in Oslo, Norway and registered at ExternalRef removed (NCT01919151). Clinical data were recorded prospectively in a database that was approved by and maintained as regulated by the Oslo University Hospital guidelines, supervised by the Data Protection Officer for Research.
: Not applicable.
: None of the authors has any conflicting interest to disclose.